Ascelia Pharma AB (publ) (ACE.ST)
Ascelia Pharma AB (publ), a biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
0.53+0.05%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-88.6%
The outlook
Ascelia Pharma AB (publ) currently reads as leaning bearish based on below its 50- & 200-day averages, 2% of the way from its 52-week low to high, avg target +438% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Price targetAvg target +438% vs current price
Analyst price target
~12-month · 3 analysts2.87average target+437.8% vs now
Now 0.53
Low 1.20High 3.70
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$71.2M
52-wk high
5.23
52-wk low
0.46
50-day avg
2.02
200-day avg
2.75
Trailing P/E
—